Inflammation

1.5 Credits / Immunology, Allergy

Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know

Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-Based Treatment

1.5 Credits / Immunology

1.5 Credits / Dermatology, Immunology

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.0 Credit / Immunology, Neurology

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Immunology, Pulmonology/Respiratory

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology

1.5 Credits / Allergy, Immunology

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

More News

December 19th 2022

Improved Voice Quality, Satisfaction Linked to Endoscopic Sinus Surgery

This new study, which followed patients up to 6 months after functional endoscopic sinus surgery, evaluated results using objective and subjective measures.

December 16th 2022

Managing GI Symptoms During OIT for Food Allergies

Though a large proportion of patients receiving oral immunotherapy (OIT) for food allergy report gastrointestinal (GI) symptoms, a knowledge gap remains for the best approach to determine the underlying etiology and manage symptoms.

December 15th 2022

Modified Elimination Diet May Be Effective in Children With Eosinophilic Gastrointestinal Disorders

Based on their retrospective findings, the researchers suggest the diet is a potentially effective option for these patients who may face challenges with other elimination diets.

December 5th 2022

Long-term Dupilumab Effective in Patients With Asthma, Including Those With Nasal Polyps

Julia Bonavitacola

Patients with asthma who were with or without a diagnosis of nasal polyps were found to have results with long-term dupilumab.

November 30th 2022

BMI Implicated in Glucocorticoid Insensitivity in CRSwNP

The investigators of this study compared outcomes between patients who had eosinophilic or noneosinophilic chronic rhinosinusitis with nasal polyps (CRSwNP) by comparing the influence of body mass index (BMI) on each disease subtype.

Image of chronic rhinosinusitis research

November 28th 2022

Dupilumab Efficacy Confirmed in CRSwNP Subgroup Study

Researchers investigated subgroups of patients with chronic rhinosinusitis with polyposis (CRSwNP), wanting more data on their responses to dupilumab and hoping to stratify their level of benefit.

November 25th 2022

Researchers Use GI Device to Target Early Esophageal Scarring in Pediatric EoE

AJMC Staff

The findings mean that scarring in the esophagus as a result of eosinophilic esophagitis (EoE) can be found earlier, allowing for more targeted intervention.

November 23rd 2022

Potential Relationship Found Between SERPINB10 Expression, CRSwNP Recurrence

This new study explored how expression of SERPINB10 may be related to postoperative recurrence of and inflammation related to chronic rhinosinusitis with nasal polyps (CRSwNP).

November 23rd 2022

Exploring Current Eosinophilic Gastrointestinal Disease Nomenclature and Management

Rose McNulty

An article published in the journal Gastroenterology & Hepatology highlights recent updates to eosinophilic gastrointestinal disease nomenclature, as well as updates related to diagnosis, pathogenesis, and treatment standards.

November 21st 2022

Previous Infections May Increase Risk of EoE, Study Finds

Jared Kaltwasser

The study findings suggest that eosinophilic esophagitis (EoE), like other atopic diseases, may be associated with infections.

November 19th 2022

Disease Characteristics Vary Widely Among Patients With CRSwNP or CRSsNP

The investigators of this new study wanted to more clearly define the patient characteristics of the 2 main types of chronic rhinosinusitis: with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP).

November 9th 2022

Nasal Cytology Produces Comparable Results to Surgery in CRSwNP

The investigators of a new study evaluated if nasal cytology was a reliable method to identify type 2 inflammation in patients who have chronic rhinosinusitis with nasal polyps (CRSwNP), which could then facilitate patient selection for biological drug utilization via endotypization.

October 31st 2022

Urgent Need for CRSwNP Treatment Optimization in Finland

A significant uptick in chronic rhinosinusitis with nasal polyps (CRSwNP) among patients with comorbid asthma has been seen in the country over the past decade.

October 27th 2022

Minor Motility Disorders Common in EoE, Says Meta-Analysis

The findings follow recent data suggesting that esophageal dysmotility may be associated with eosinophilic esophagitis (EoE), which often presents with dysphagia.

Image of foods that can trigger a reaction

October 26th 2022

Fixed Structural Disease May Predict EoE Response to Elimination Diet

The study, say researchers, adds insight into risk factors predictive of response to dietary intervention for eosinophilic esophagitis (EoE), as dietary failure occurs in up to 30% of patients.

October 22nd 2022

New Index Aims to Help Clinicians Gauge Severity of EoE Cases

Jared Kaltwasser

The index for eosinophilic esophagitis (EoE) was crafted based on a literature review by a multidisciplinary team of experts.

October 20th 2022

CRSwNP Likely Leads to Greater Overall Disease Burden Following Surgery

The goal of this new study was to gain more information on the disease burden, including costs, of patients living with chronic rhinosinusitis with nasal polyps (CRSwNP).

October 18th 2022

Patients With Asthma, Other Allergic Diseases May Have Higher Prevalence of EoE

While the prevalence of eosinophilic esophagitis (EoE) is estimated to be 0.5% in the general population, a recent study found that the prevalence was as high as 16.5% in patients with allergic disease.

October 12th 2022

Review Finds Insufficient Evidence Supporting Corticosteroid Irrigation for CRS With Nasal Polyps

Christina Mattina

A search of the peer-reviewed literature turned up inconsistent findings on the effectiveness of corticosteroid irrigation for the treatment of chronic rhinosinusitis (CRS) with nasal polyps.

October 8th 2022

Dupilumab Outcomes Similar in CRSwNP Among Treatment-Naïve, Postsurgical Patients

The effect of dupilumab was investigated among patients with severe and uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP).

Image of a person with an irritated nose

October 4th 2022

Periostin as Biomarker May Be More Useful Than Eosinophils in ECRS

Despite extensive study, eosinophilic chronic rhinosinusitis (ECRS) remains a significant health problem with few effective treatments, so this study compared periostin levels among those who did and did not have ECRS to assess its potential as a disease biomarker.

September 30th 2022

Four Factors Identified as Potential Risks for Comorbid CRSwNP, Asthma

Researchers investigated potential risk factors for the higher occurrence of asthma among individuals who have chronic rhinosinusitis with nasal polyps (CRSwNP).

September 28th 2022

Real-world EoE Data Show More, Quicker Responses Among Concurrent Eczema, PFS

Overall, 65% of patients went into remission throughout the observation period, with those with concurrent eczema and pollen food syndrome (PFS) having favorable responses.

September 28th 2022

Pediatric ESS Effective, Safe to Treat Chronic Sinusitis With Nasal Polyps

With a high recurrence rate following surgery to treat chronic sinusitis with nasal polyps, authors set out to investigate the effectiveness and safety of endoscopic sinus surgery (ESS) in a pediatric patient population.

September 23rd 2022

Examining Biologic-Related Adverse Events in CRS With Nasal Polyps

Matthew Gavidia

Headaches, injection site reactions, and pharyngitis were the most common adverse events associated with the biologic therapies dupilumab, omalizumab, mepolizumab, and reslizumab in the treatment of chronic rhinosinusitis (CRS) with nasal polyps.

September 17th 2022

Antibody Level Linked to Milk Proteins, Consumption in Eosinophilic Esophagitis

Allison Inserro

It is already known that patients with eosinophilic esophagitis have higher levels of immunoglobulin G4, and this study examined the relationship to specific foods and aeroallergens.

Graphic showing figure on the outside of a group

September 15th 2022

Researchers Evaluate Racism as a Factor in Underestimation of Atopic Disease

Allison Inserro

Although allergic and atopic disease is well studied and researched overall, the researchers said there is a critical lack of knowledge about these conditions, including eosinophilic esophagitis, asthma, and atopic dermatitis, in diverse racial and ethnic groups.

September 14th 2022

Risk Factors for CRS Plus Asthma Differ Among Younger vs Older Patients

Risk factors as predictors of asthma prevalence among a cohort of patients living with chronic rhinosinusitis (CRS), as they related to age, were evaluated by clinical investigators from the College of Medicine at Korea University.

September 9th 2022

SCS Use May Predispose Patients Who Have CRSwNP to Worse Health Outcomes